SCHEMBL4533417

SCHEMBL4533417

O=C(NO)C(c1ccccc1)N1CCC2(CC1)OCCCO2

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.66
KMT2A Q03164 1/20 0.66
LMNA P02545 3/20 0.61
NPSR1 Q6W5P4 2/20 0.61
HTT P42858 1/20 0.61
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP2D6 P10635 1/20 0.50
MAPK1 P28482 1/20 0.50
TSHR P16473 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.44
OPRM1 P35372 2/20 0.44
OPRK1 P41145 2/20 0.44
OPRL1 P41146 2/20 0.44
OPRD1 P41143 1/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2843906 0.79 ALDH1A1 (0.65) ALDH1A1LMNAHTTCYP3A4CYP2C19
SCHEMBL2846505 0.79 GAA (0.68) ALDH1A1KMT2ALMNACYP3A4CYP2C19
SCHEMBL2842642 0.77 OPRL1 (0.70) OPRM1OPRK1OPRL1OPRD1
SCHEMBL8112806 0.76 OPRM1 (0.51) ALDH1A1KMT2ALMNANPSR1HTT
SCHEMBL4529459 0.73 ADRA1D (0.54) ALDH1A1KMT2AOPRM1OPRK1OPRL1
SCHEMBL27777209 0.73 ALDH1A1 (0.67) ALDH1A1KMT2ANPSR1CYP3A4CYP2C19
SCHEMBL2841585 0.72 NPY2R (0.51) ALDH1A1KMT2ALMNANPSR1CYP3A4
SCHEMBL27798585 0.71 CYP3A4 (0.58) ALDH1A1KMT2ALMNAHTTCYP3A4
SCHEMBL2867132 0.70 MAOB (0.64) ALDH1A1KMT2ALMNANPSR1HTT
SCHEMBL2842489 0.70 TSHR (0.52) ALDH1A1KMT2ALMNACYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 532/4885KMT2A 58/4885LMNA 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.